News for Healthier Living

RP1 Oncolytic Therapy Provides New Hope for Patients Whose Melanoma Resists Conventional Immunotherapy

About half of all patients with advanced melanoma face a poor prognosis because their cancer doesn't respond to immunotherapy -- but results of a recent clinical trial show that an unusual treatment strategy could change that.

August 18, 2025


August 21 2025

August 20 2025

August 19 2025

August 18 2025

August 17 2025

August 16 2025

August 15 2025

August 14 2025

August 13 2025

August 12 2025

August 11 2025

August 10 2025

August 9 2025

August 8 2025

August 7 2025